| RS2101077991 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101078030 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101078285 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2101078317 |
ABCA4
|
Health Risk |
Likely pathogenic |
Abnormality of the eye, Abnormality of the eye |
| RS2101078370 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101078386 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101078458 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101078482 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease 3, Stargardt disease 3 |
| RS2101079010 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101079015 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2101079061 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101079369 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101079417 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101079462 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS2101084835 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101085885 |
DRAM2
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 21, Cone-rod dystrophy 21 |
| RS2101086076 |
DRAM2
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 21, Cone-rod dystrophy 21 |
| RS2101087046 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101087361 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101094012 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101095108 |
WARS2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, mitochondrial |
| RS2101098803 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101101226 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101101348 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2101101390 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101101428 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101104619 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101106481 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101106559 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101106686 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101106736 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101107081 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101107143 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101110148 |
LRIF1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 3, digenic |
| RS2101111970 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101112150 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101112572 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101113398 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101114577 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101121827 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS2101122493 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101126325 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101128055 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101128697 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101131514 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2101132362 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101132521 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2101133098 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2101135424 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2101135446 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101135952 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
ABCA4-related retinopathy, ABCA4-related retinopathy |
| RS2101136443 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101136597 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101136632 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101136881 |
AGL
|
Health Risk |
Pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2101137614 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a NOTCH2 point mutation, Hajdu-Cheney syndrome |
| RS2101139955 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101141863 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101142159 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101142622 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101142928 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101143618 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Hajdu-Cheney syndrome |
| RS2101144082 |
NOTCH2
|
Health Risk |
Likely pathogenic |
See cases, Alagille syndrome due to a NOTCH2 point mutation |
| RS2101144806 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101145073 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS2101145154 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101145406 |
NOTCH2
|
Health Risk |
Pathogenic |
Keratoacanthoma, Keratoacanthoma |
| RS2101148246 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101148971 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101149228 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2101151409 |
NOTCH2
|
Health Risk |
Likely pathogenic |
— |
| RS2101154713 |
AMPD2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 9, Pontocerebellar hypoplasia type 9 |
| RS2101154903 |
AMPD2
|
Health Risk |
Likely pathogenic |
— |
| RS2101155246 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101155690 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101156021 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101156046 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101156053 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101156061 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101158688 |
AMPD2
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2101160151 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101160478 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101160657 |
AMPD2
|
Health Risk |
Pathogenic |
Spastic ataxia, Spastic ataxia |
| RS2101162260 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101162359 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101162548 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101162564 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2101162618 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Alagille syndrome due to a NOTCH2 point mutation |
| RS2101167069 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101191227 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101191402 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2101195348 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101195764 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2101198087 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101205361 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101213034 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2101216259 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101219709 |
C8A
|
Health Risk |
Pathogenic |
— |
| RS2101220673 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2101221217 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |